A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of Nuclear Medicine. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel PET radiotracer for evaluation of possible MI and ischemia. The approval is based on ...

In the featured article of the March 2017 issue of "The Journal of Nuclear Medicine," researchers demonstrate that a new positron emission tomography (PET) radiotracer, gallium-68 (Ga-68)-pentixafor, ...

A new radiotracer, 68 Ga-FAP-2286, has been found to be more effective than the most commonly used nuclear medicine cancer imaging radiotracer, 18 F-FDG. In a study published in the March issue of The ...

A new PET radiotracer can differentiate diseased tissues from healthy tissues based on fructose metabolism, according to new research published in the March issue of The Journal of Nuclear Medicine.

Researchers in the U.S. and U.K. have developed what they say is a more accurate way to scan for tuberculosis (TB) using positron emission tomography (PET) to detect the causative Mycobacterium ...

Please provide your email address to receive an email when new articles are posted on . PET with the radiotracer 18F flurpiridaz had better sensitivity and similar specificity vs. SPECT in patients ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer picture into blocked arteries in the heart and any damage to cardiac tissue.

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...

Elevated standard uptake values were seen for 11 brain regions, including regions that support cognition. (HealthDay News) — Intranasal administration of [68 Ga]Ga-NOTA-insulin is safe and delivers ...

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...

Reston, VA (March 28, 2025)—A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of ...